Dudediligence.

Climb Bio, Inc

CLYMNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

57.4M

on 2026-06-30, from 27.7M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

20M40M60MMar2024JunSepDecMar2025JunSepDecMar2026Jun$9.50

Newest

$200.0M

S-3 of 2024-11-12. 2 prospectus supplements filed under it since. S-3 ↗

$100.0M

Jefferies, agreement of 2026-06-12. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-06 is not read yet.

Cash

13.9 quarters

$183.1M on 2026-06-30 ÷ $13.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-04-27Private placement incl. 2.11M pre-funded11,587,000$9.50$110.0M8-K ↗